[HTML][HTML] Response to imatinib mesylate in patients with chronic myeloproliferative diseases with rearrangements of the platelet-derived growth factor receptor beta

…, A Chase, JM Chessells, M Colombat… - … England Journal of …, 2002 - Mass Medical Soc
Background A small proportion of patients with chronic myeloproliferative diseases have
constitutive activation of the gene for platelet-derived growth factor receptor beta (PDGFRB), …

Serum hepatitis B virus DNA levels and liver histology in inactive HBsAg carriers

M Martinot-Peignoux, N Boyer, M Colombat… - Journal of …, 2002 - Elsevier
Background/Aims: A recent NIH research workshop on hepatitis B virus (HBV) revisited the
definition of healthy HBsAg carriers. The new definition inactive surface antigen (HBsAg) …

[PDF][PDF] Obesity and diabetes as a risk factor for hepatocellular carcinoma

JM Regimbeau, M Colombat, P Mognol… - Liver …, 2004 - Wiley Online Library
Ten percent of patients who undergo resection for hepatocellular carcinoma (HCC) associated
with chronic liver disease have no detectable cause for this underlying liver disease. …

Recurrent RAS and PIK3CA mutations in Erdheim-Chester disease

…, C Le Gall, K Leroy, M Colombat… - Blood, The Journal …, 2014 - ashpublications.org
Erdheim-Chester disease (ECD) is a rare histiocytic disorder that is challenging to diagnose
and treat. We performed molecular analysis of BRAF in the largest cohort of ECD patients …

Pulmonary vascular lesions in end-stage idiopathic pulmonary fibrosis: histopathologic study on lung explant specimens and correlations with pulmonary …

M Colombat, H Mal, O Groussard, F Capron, G Thabut… - Human pathology, 2007 - Elsevier
In patients presenting with idiopathic pulmonary fibrosis (IPF), modifications of pulmonary
vessels are well defined in fibrotic areas but have not been accurately assessed in the …

Pulmonary cystic disorder related to light chain deposition disease

M Colombat, M Stern, O Groussard, D Droz… - American journal of …, 2006 - atsjournals.org
Light chain deposition disease (LCDD) is a rare disorder that very uncommonly affects the
lung. We report three cases of severe cystic pulmonary LCDD leading to lung transplantation. …

Eculizumab for treatment of rapidly progressive C3 glomerulopathy

…, C Kandel, F Bourdon, V Gnemmi, M Colombat… - American Journal of …, 2015 - Elsevier
… Eculizumab use was associated with significant improvement in kidney function, with
estimated glomerular filtration rates of patients increasing 22 to 38 mL/min/1.73 m 2 . Eculizumab …

Clinical and morphologic spectrum of renal involvement in patients with mixed cryoglobulinemia without evidence of hepatitis C virus infection

M Matignon, P Cacoub, M Colombat, D Saadoun… - Medicine, 2009 - journals.lww.com
… in all patients, nephrotic range proteinuria in 75% of patients, hypertension in 80% of patients,
and renal failure in 85% of patients (mean glomerular filtration rate, 46 mL/min per 1.73 m

Dramatic beneficial effect of interleukin-1 inhibitor treatment in patients with familial Mediterranean fever complicated with amyloidosis and renal failure

…, J Peltier, G Pelle, I Jéru, M Colombat… - Nephrology Dialysis …, 2012 - academic.oup.com
Background. Familial Mediterranean fever (FMF) is an autosomal recessive autoinflammatory
disorder, for which systemic AA amyloidosis is the major complication revealed most of the …

Atrial fibrillation and subtype of atrial fibrillation in cardiac amyloidosis: clinical and echocardiographic features, impact on mortality

K Sanchis, E Cariou, M Colombat, D Ribes, A Huart… - Amyloid, 2019 - Taylor & Francis
Background: Atrial fibrillation (AF) commonly affects patients with cardiac amyloidosis (CA).
Amyloid deposition within the left atrium may be responsible for the subtype of AF in either …